Diabetic Ulcers Treatment Market Outlook:
Diabetic Ulcers Treatment Market size was valued at USD 8.81 billion in 2025 and is likely to cross USD 15.93 billion by 2035, expanding at more than 6.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of diabetic ulcers treatment is assessed at USD 9.29 billion.
Key Diabetic Ulcer Treatment Market Insights Summary:
Regional Highlights:
- North America diabetic ulcers treatment market is predicted to capture 38.8% share by 2035, driven by the increasing spending on healthcare and the presence of key market players in the region.
Segment Insights:
- The foot ulcer segment in the diabetic ulcers treatment market is projected to capture the largest share by 2035, driven by the increasing global prevalence of diabetic foot ulcers.
- The hospitals segment in the diabetic ulcers treatment market is anticipated to hold a significant share by 2035, fueled by a rising aging population and improved treatment facilities in hospitals.
Key Growth Trends:
- Lack of Awareness About Diabetic Ulcers
- Rise in the Number of Inactive Lifestyles that Increases Chances of Obesity and Diabetes
Major Challenges:
- Growing Prevalence of Periodontal (Gum) Disease Worldwide
- High Cost Associated with the Foot Ulcer Treatment
Key Players: Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Medtronic Plc, Hill-Rom Holdings, Inc., ConvaTec Inc.
Global Diabetic Ulcer Treatment Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 8.81 billion
- 2026 Market Size: USD 9.29 billion
- Projected Market Size: USD 15.93 billion by 2035
- Growth Forecasts: 6.1% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (38.8% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Japan, United Kingdom, France
- Emerging Countries: China, India, Brazil, Mexico, Thailand
Last updated on : 8 May, 2025
A growing number of people being diagnosed with diabetes worldwide is the primary factor for the market's growth. In 2019, diabetes caused 1.5 million deaths directly, with 48% of fatalities occurring before 70 years of age, according to the World Health Organization. The American Diabetes Association reported that nearly 37.3 million Americans, or 11.3% of the population, have diabetes. A total of 28.7 million of them are diagnosed, whilst 8.5 million remain undiagnosed. Diabetes is one of the common diseases that can affect people at a younger age. Moreover, increasing obesity issues, genetics, unhealthy diet habits, and urbanization are some of the reasons for the increase in diabetes risk.
The most common type of diabetic ulcer is a foot ulcer which is an open sore or wound and occurs in approximately 15 percent of diabetic patients. A foot ulcer is commonly found on the bottom of the foot. Six percent of those who develop a foot ulcer will require hospitalization for infection or other ulcer-related complications. The treatment for diabetic ulcers involves debriding the wound, treating any infection, revascularizing the area, and off-loading the area. Furthermore, growing awareness of treatment options for diabetic ulcers, improvements in treatment procedures, the approval of new products, and increasing research and development expenditure are projected to drive market growth over the forecast period. According to a recent report by the World Bank, global research and development expenditures are expected to be 2.63 percent of the country's total Gross Domestic Product (GDP) in 2020. The growth is considerably higher than 2.2% in 2018.
Diabetic Ulcers Treatment Market Growth Drivers and Challenges:
Growth Drivers
- Growing Prevalence of Periodontal (Gum) Disease Worldwide - According to the World Health Organization, about 14% of the global adult population suffers from severe periodontal disease, which comprises more than 1 billion cases worldwide. As a result of gum disease, blood sugar levels can increase, which can further exacerbate the problems associated with diabetes, such as heart disease, blood vessel problems, eye problems, kidney problems, and nerve problems. Consequently, poor oral hygiene may contribute to diabetes, which can lead to mouth ulcers. This factor is projected to propel the demand for diabetic ulcer treatment during the forecast period.
- Rise in the Number of Inactive Lifestyles that Increases Chances of Obesity and Diabetes - About 60% of U.S. adults do not engage in adequate physical activity, according to the Centers for Disease Control and Prevention. It is estimated that nearly 25 percent of American adults are completely inactive.
- Huge Base of Geriatric Population Worldwide Who are More Prone to Diabetes - At the end of 2021, there were 747,238,580 people over 60 years of age living in the world, according to the World Bank. In the future, the number is expected to increase.
- Growing Personal Disposable Income Which Changes Lifestyle Habits - According to the Bureau of Economic Analysis, personal income grew by USD 47.0 billion (0.2%) in July 2022, while disposable personal income rose by USD 37.6 billion (0.2%).
- Rising Prevalence of Fissured Tongue in Diabetes Owing to Reduced Saliva Flow - For instance, the global prevalence of fissured tongue among diabetic patients is 17% . Diabetes patients showed more of this alteration of 15% than non-diabetics of 11%.
Challenges
- Lack of Awareness About Diabetic Ulcers – A large percentage of the population is unaware of the identifying characteristics of diabetic ulcers, often mistaking them for normal ulcers until the disease progresses. Hence, awareness needs to spread about this condition and how to diagnose it.
- Lack of Raw Materials and Supply Due to COVID-19
- High Cost Associated with the Foot Ulcer Treatment
Diabetic Ulcers Treatment Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
6.1% |
|
Base Year Market Size (2025) |
USD 8.81 billion |
|
Forecast Year Market Size (2035) |
USD 15.93 billion |
|
Regional Scope |
|
Diabetic Ulcers Treatment Market Segmentation:
Ulcer Type Segment Analysis
The global diabetic ulcers treatment market is segmented and analyzed for demand and supply by ulcer type into foot ulcer, mouth ulcer, and others. Among these segments, the foot ulcer segment is anticipated to capture the largest market size owing to the rapidly growing number of people around the world who are experiencing diabetic foot ulcers (DFUs). A diabetic foot ulcer is a very serious condition in diabetic patients, as the immunity power and wound healing process are compromised in these people. The wound is even prone to get infectious over time if proper medications are not taken. For instance, every year, it is estimated that 9 to 26 million people around the world suffer from diabetic foot ulcers as a result of their diabetes. There is a significant chance that a diabetic foot ulcer will develop over the course of a patient's lifetime in 16 to 24% of patients with diabetes.
End-user Segment Analysis
The global diabetic ulcers treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and home care. Amongst these segments, the hospitals segment is expected to garner a significant share. The increasing number of hospitals across the world owing to the increasing number of patients suffering from various diseases, and the growing aging population is estimated to propel the growth of the market segment. The increasing favorable reimbursement policies from the government to support people with low income rises the demand for hospitals. The improvement in treatment methods and the presence of experienced doctors in the hospitals is expected to increase the market segment growth in the forecast period. As per the estimations, there are about 8,200 hospitals in Japan as of 2020 and 4,100 hospitals in Korea.
Our in-depth analysis of the diabetic ulcers treatment market includes the following segments:
|
By Ulcer Type |
|
|
By Treatment Type |
|
|
By End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Diabetic Ulcers Treatment Market Regional Analysis:
North American Market Insights
The North America diabetic ulcers treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the increasing spending on healthcare along with the presence of key market players in the region. The Centers for Medicare & Medicaid Services has reported that US healthcare spending in 2020 totaled USD 4.1 trillion, which represents 19.7% of the nation’s gross domestic product. Additionally, the increasing adoption of wound care products, coupled with the surging awareness regarding chronic wound care, the rise in technologically advanced research and development activities, and the huge diabetic population in the North America region are expected to fuel the diabetic ulcers treatment market growth in the region during the forecast period. The increasing urbanization and change in lifestyle, which include improper eating habits and a lack of exercise, are estimated to project market growth in the region as these factors increase the risk of diabetes. The rising number of the age-old population who have diabetes and foot ulcer issues are further predicted to boost the market’s growth in the region.
Diabetic Ulcers Treatment Market Players:
- Orpyx Medical Technologies Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- PENTAX Medical
- Smith & Nephew plc
- Organogenesis Inc.
- SIGVARIS GROUP
- 3M
- Molnlycke Health Care AB,
- Medtronic Plc
- Hill-Rom Holdings, Inc.
- ConvaTec Inc.
Recent Developments
-
Orpyx Medical Technologies Inc., a company specializing in digital health therapeutics, has launched Orpyx SI Sensory Insoles incorporated with remote patient monitoring technology for the prevention of diabetic foot ulcers (DFUs) and ulcers associated with neuropathy.
-
As part of its therapeutic accessories portfolio, PENTAX Medical has launched a range of platforms dedicated to electrosurgical and argon plasma coagulation (APC) techniques - the ENDO ARC and ENDO PLUS.
- Report ID: 4585
- Published Date: May 08, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Diabetic Ulcer Treatment Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
